Oppenheimer Downgrades Idenix Pharmaceuticals Inc. (IDIX) to Perform
Tweet Send to a FriendGet Alerts IDIX Hot Sheet
Price: $5.39 +3.65%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade IDIX Now!
Oppenheimer downgraded Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) from Outperform to Perform.
For more ratings news on Idenix Pharmaceuticals Inc. click here and for the rating history of Idenix Pharmaceuticals Inc. click here.
Shares of Idenix Pharmaceuticals Inc. closed at $4.01 yesterday, with a 52 week range of $2.57-$6.11.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Idenix Pharmaceuticals Inc. click here and for the rating history of Idenix Pharmaceuticals Inc. click here.
Shares of Idenix Pharmaceuticals Inc. closed at $4.01 yesterday, with a 52 week range of $2.57-$6.11.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- Goldman Sachs Upgrades Enbridge (ENB) to Conviction Buy
- UPDATE: Canaccord Genuity Starts T-Mobile US, (TMUS) at Hold
Create E-mail Alert Related Categories
Downgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
